Scope and purpose of the guideline

Need for a revised management guideline
The British Society for Rheumatology/British Health Professionals in Rheumatology guideline for the management of gout was published in 2007 1 . A revised and updated guideline is now required because of the availability of new pharmaceutical treatment options; recent increases in the incidence, prevalence and severity of gout 2 ; continuing suboptimal management in both primary and secondary care 2,3 ; and better understanding of patient and provider barriers to effective care. 4, 5 
Objectives of the guideline
To offer revised and updated, concise, patient-focussed, evidence-based, expert recommendations for the management of gout in the UK.
Target Audience
To provide assistance to doctors and allied health professionals who treat and manage patients with gout in primary care and hospital practice.
Areas that the guideline does not cover
This guideline does not cover the diagnosis and investigation of gout. This guideline has been reviewed and endorsed by the Royal College of General Practitioners (RCGP). 
Key recommendations from this guideline
The full guideline, available at Rheumatology online, contains specific recommendations for management of gout in special groups: patients with renal sufficiency, severe refractory tophaceous gout, and in pregnancy. Figure 1 illustrates the suggested care pathway.
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Figure 1
Algorithm for the management of gout
